Net Income (Quarterly) Chart

View Net Income (Quarterly) for GNGBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 89.59M
March 31, 2026 43.98M
December 31, 2025 92.38M
September 30, 2025 60.52M
June 30, 2025 54.55M
March 31, 2025 28.48M
December 31, 2024 61.96M
September 30, 2024 0.8635M
June 30, 2024 47.99M
March 31, 2024 44.63M
December 31, 2023 67.40M
September 30, 2023 83.33M
June 30, 2023 20.49M
March 31, 2023 56.80M
December 31, 2022 52.31M
September 30, 2022 76.30M
June 30, 2022 62.04M
March 31, 2022 57.59M
December 31, 2021 87.45M
September 30, 2021 88.70M
June 30, 2021 95.81M
March 31, 2021 77.59M
December 31, 2020 128.20M
September 30, 2020 157.31M
June 30, 2020 51.36M
Date Value
March 31, 2020 28.61M
December 31, 2019 94.62M
September 30, 2019 22.73M
June 30, 2019 11.75M
March 31, 2019 1.853M
December 31, 2018 79.05M
September 30, 2018 -161.41M
June 30, 2018 10.48M
March 31, 2018 -37.10M
December 31, 2017 115.38M
September 30, 2017 15.34M
June 30, 2017 -9.657M
March 31, 2017 13.11M
December 31, 2016 96.39M
September 30, 2016 -9.505M
June 30, 2016 27.63M
March 31, 2016 13.59M
December 31, 2015 117.54M
September 30, 2015 20.50M
June 30, 2015 21.04M
March 31, 2015 12.83M
December 31, 2014 133.90M
September 30, 2014 52.97M
June 30, 2014 60.73M
March 31, 2014 -51.06M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Xvivo Perfusion AB 1.739M
Paxman AB 0.2737M
Enovis Corp. -1.036M
Edwards Lifesciences Corp. 241.40M
Intuitive Surgical, Inc. 823.20M